CARLA CAPPADORO: Open Payments
NPI 1821165150 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 33 payments from 12 companies in 2025. Trend: 2023 $1,393 · 2024 $1,137 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $138 |
| PFIZER INC. | 6 | $125 |
| Merck Sharp & Dohme LLC | 5 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| Actelion Pharmaceuticals US, Inc. | 2 | $66 |
| Boston Scientific Corporation | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
Products named: JARDIANCE, ELIQUIS, UPTRAVI, Kerendia, VYNDAQEL, FARXIGA, LifeVest, LEQVIO.
Industry payments across FL — which companies pay providers there.
